Copy to clipboard 
Oxford Performance Materials (OPM) customer Vy Spine received FDA clearance for the OsteoFab Lumbar Cage, which follows its previous clearance for the OsteoFab Cervical Cage. This new product line, OsteoVy PEKK Lumbar IBF, marks another adoption of PEKK-based, non-metal implants.
OPM’s OsteoFab technology offers an alternative to metal and PEEK, utilizing PEKK (poly-ether-ketone-ketone), a biocompatible, high-performance polymer and particular characteristics:
No Metal Hypersensitivity or Metallosis: OPM’s PEKK implants are 100% polymer based. Unlike metal, OsteoFab implants do not corrode or wear within the body over time.
Radiolucency for Enhanced Imaging: Surgeons can precisely track bone healing and monitor implant positioning to help ensure successful patient outcomes. OsteoFab devices do not produce image scatter or artifacts and help minimize overall radiological exposure to patients and healthcare practitioners.
Reduced Stress Shielding: Unlike metal, the mechanical properties of OsteoFab are similar to cortical bone, providing the necessary strength while promoting healthy bone growth and implant stability over time. OsteoFab implants enable more natural load distribution, reducing the risk of stress shielding.
Enhanced Osseointegration: Unlike metal and PEEK, OsteoFab PEKK implants are designed to promote protein adsorption onto its surface, which facilitates bone cell attachment and growth.
“With Vy Spine’s latest clearance of the OsteoFab Lumbar Cage, we are witnessing another significant step toward safer, more advanced spinal solutions,” said Scott DeFelice, CEO of Oxford Performance Materials. “For too long, the industry has relied on metal implants despite their limitations. Vy Spine’s choice of OsteoFab supports the case for metal-free solutions to improve patient care and surgical outcomes. We believe this is continuing evidence of a broader industry shift.”
Source: Oxford Performance Materials
